$30.95
2.157.47%
At Close: -
$30.95
00.00%
After Hours: 4:52 PM EDT
15 minutes delayed
Comments
Loading...
Spyre Therapeutics
SYRENASDAQ
Spyre Therapeutics (NASDAQ:SYRE) Stock, Earnings Estimates, EPS, And Revenue
Spyre Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 9
EPS Estimate
$-0.950
Quarterly Revenue Estimate
$4M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$688K
Analyze the earnings history of Spyre Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics | -$41.50 | -$0.95 | — | — | $688.00K | $4.00M | — | — | 08/09/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$5.00 | -$1.17 | -$1.20 | -2.56% | $198.00K | — | $0.00 | — | 05/09/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$5.00 | -$0.78 | -$4.05 | -419.23% | $168.00K | $220.00K | $0.00 | -100.00% | 02/29/2024 | Get Alert |
| SYRE | Spyre Therapeutics | -$4.75 | -$0.84 | -$9.34 | -1011.90% | $174.00K | — | $0.00 | — | 11/09/2023 | Get Alert |
| SYRE | Aeglea BioTherapeutics | -$6.75 | -$3.75 | -$41.50 | -1006.67% | $625.00K | $200.00K | $688.00K | 244.00% | 08/11/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$9.25 | -$4.50 | -$5.00 | -11.11% | $1.36M | $120.00K | $198.00K | 65.00% | 05/11/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.75 | -$5.00 | -$4.50 | 10.00% | $3.64M | $60.00K | $168.00K | 180.00% | 03/02/2023 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.75 | -$5.75 | -$4.75 | 17.39% | $1.40M | $210.00K | $174.00K | -17.14% | 11/03/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$2.50 | -$7.75 | -$6.75 | 12.90% | $0.00 | — | $625.00K | — | 08/04/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.00 | -$8.50 | -$9.25 | -8.82% | $0.00 | $1.32M | $1.36M | 3.18% | 05/05/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$8.50 | -$7.25 | -$7.75 | -6.90% | $0.00 | $3.07M | $3.64M | 18.70% | 03/08/2022 | Get Alert |
| SYRE | Spyre Therapeutics | -$7.25 | -$7.00 | -$7.75 | -10.71% | $0.00 | $4.05M | $1.40M | -65.46% | 11/04/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$10.00 | -$4.00 | -$2.50 | 37.50% | $0.00 | — | $0.00 | — | 08/05/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$14.25 | -$4.25 | -$7.00 | -64.71% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$16.25 | -$7.75 | -$8.50 | -9.68% | $0.00 | — | $0.00 | — | 03/18/2021 | Get Alert |
| SYRE | Spyre Therapeutics | -$16.50 | -$9.75 | -$7.25 | 25.64% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$13.75 | -$11.00 | -$10.00 | 9.09% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$14.75 | -$16.50 | -$14.25 | 13.64% | $0.00 | — | $0.00 | — | 05/07/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$16.00 | -$17.00 | -$16.25 | 4.41% | $0.00 | — | $0.00 | — | 02/24/2020 | Get Alert |
| SYRE | Spyre Therapeutics | -$13.50 | -$13.50 | -$16.50 | -22.22% | $0.00 | — | $0.00 | — | 11/06/2019 | Get Alert |
| SYRE | Spyre Therapeutics | -$11.50 | — | -$13.75 | — | $2.38M | — | $0.00 | — | 08/06/2019 | Get Alert |
Spyre Therapeutics (SYRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-1.20 | $-1.17 | -2.56 % |
| Dec 2023 | 2024-02-29 | $-4.05 | $-0.78 | -419.2 % |
| Sep 2023 | 2023-11-09 | $-9.34 | $-0.84 | -1011.9 % |
| Jun 2023 | 2023-08-11 | $-41.50 | $-3.75 | -1006.7 % |
Spyre Therapeutics (SYRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-29 | $0 | $220.00K | -100.0 % |
| Jun 2023 | 2023-08-11 | $688.00K | $200.00K | 244.0 % |
| Mar 2023 | 2023-05-11 | $198.00K | $120.00K | 65.0 % |
| Dec 2022 | 2023-03-02 | $168.00K | $60.00K | 180.0 % |
FAQ
When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?
Spyre Therapeutics (SYRE) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Spyre Therapeutics (NASDAQ:SYRE)?
The Actual EPS was $-1.20, which missed the estimate of $-1.17.
What were Spyre Therapeutics’s (NASDAQ:SYRE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.